Albanese, A., Kewley, G.D., Long, A., Pearl, K.N., Robins, D.G. and Stanhope, R. (1994) Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate. Archives of Disease in Childhood 71, 315-317.
Beiner, J.M., Jokl, P., Cholewicki, J. and Panjabi, M.M. (1999) The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury. American Journal of Sports Medicine. 27, 2-9.
Bhasin, S., Storer, T.W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T.J., Tricker, R., Shirazi, A. and Casaburi, R. (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in men. New England Journal of Medicine 335, 1-7.
Climstein, M., O'Shea, P., Adams, K.J. and DiBeliso, M. (2003) The effects of anabolic-androgenic steroids upon resting and peak exercise left ventricular heart wall motion kinetics in male strength and power athletes. Journal of Science and Medicine and Sport. 6, 387-397.
Cohen, J.C., Faber, W.M., Spinnler Benade, A.J. and Noakes, T.D. (1986) Altered serum lipoprotein profiles in male and female power lifters ingesting anabolic steroids. Physician and Sportsmedicine 14, 131-136.
David, H.G., Green, J.T., Green, A.J. and Wilson, C.A. (1994) Simultaneous bilateral quadriceps rupture: a complication of anabolic steroid use. Journal of Bone and Joint Surgery, British Volume 77, 159-160.
Dhar, R., Stout, C.W., Link, M.S., Homoud, M.K., Weinstock, J. and Estes, N.A. III. (2005) Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clinic Proceedings 80, 1308-1315.
Dubin, C. (1990) Commission of inquiry into the use of drugs and banned practices intended to increase athletic performance. (Catalogue No. CP32-56/1990E, ISBN 0-660-13610-4). Ottawa, ON: Canadian Government Publishing Center.
Fahey, T.D. and Brown, C.H. (1973) The effects of an anabolic steroid on the strength, body composition, and endurance of college males when accompanied by a weight training program. Medicine and Science in Sports 5, 272-276.
Ferreira, I.M., Verreschi, I.T., Nery, L.E., Goldstein, R.S., Zamel, N., Brooks, D. and Jardim, J.R. (1998) The influence of 6 months of oral anabolic steroids on body mass and respiratory muscle sin undernourished COPD patients. Chest 114, 19-28.
Fineschi, V., Baroldi, G., Monciotti, F., Paglicci Reattelli, L. and Turillazzi, E. (2001) Anabolic steroid abuse and cardiac sudden death: A pathologic study. Archives of Pathology and Laboratory Medicine 125, 253-255.
Fleck, S.J., Pattany, P.M., Stone, M.H., Kraemer, W.J., Thrush, J. and Wong, K. (1993) Magnetic resonance imaging determination of left ventricular mass: junior Olympic weightlifters. Medicine and Science in Sports and Exercise 225, 522-527.
Fudula, P.J., Weinrieb, R.M., Calarco, J.S., Kampman, K.M. and Boardman C. (2003) An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Annals of Clinical Psychiatry 15, 121-130.
Geusens, P., Dequeker, J., Verstraeten, A., Nils, J. and Van Holsbeeck, M. (1986) Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions. Maturitas 88, 281-289.
Golding, L.A., Freydinger, J.E. and Fishel, S.S. (1974) The effect of an androgenic-anabolic steroid and a protein supplement on size, strength, weight and body composition in athletes. Physician and Sportsmedicine 2, 39-45.
Karpakka, J.A., Pesola, M.K. and Takala, T.E. (1992) The effects of anabolic steroids on collagen synthesis in rat skeletal muscle and tendon. A preliminary report. American Journal of Sports Medicine 20, 262-266.
Koskinen, E. and Katila, T. (1997) Effect of 19-norandrostenololylaurate on serum testosterone concentration, libido, and closure of distal radial growth plate in colts. Acta Veterinaria Scandinavica 38, 59-67.
Kuipers, H., Wijnen, J.A., Hartgens, F. and Willems S.M. (1991) Influence of anabolic steroids on body composition, blood pressure, lipid profile, and liver function in amateur bodybuilders. International Journal of Sports Medicine 12, 413-418.
Lee, P., Zhu, C.C., Sadick, N.S., Diwan, A.H., Zhang, P.S., Liu, J.S. and Prieto, V.G. (2005) Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia. Journal of Cutaneous Pathology 32, 567-571.
LeGros, T., McConnell, D., Murry, T., Edavettal, M., Racey-Burns, L.A., Shepherd, R.E. and Burns, A.H. (2000) The effects of 17 ?-methyltestosterone on myocardial function in vitro. Medicine and Science in Sports and Exercise 32, 897-903.
Luke, J.L., Farb, A., Virmani, R. and Barry Sample, R.H. (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. Journal of Forensic Science 35, 1441-1447.
McNutt, R.A., Ferenchick, G.S., Kirlin, P.C. and Hamlin, N.J. (1988) Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. American Journal of Cardiology 62, 164.
Michna H. (1986) Organisation of collagen fibrils in tendon: changes induced by an anabolic steroid. I. Functional and ultrastructural studies. Virchows Archive B (Cell Pathology Including Molecular Pathology) 52, 75-86.
Nahrendorf, M., Frantz, S., Hu, K., von zur Muhlen, C., Tomaszewski, M., Scheuermann, H, Kaiser, R., Jazbutyte, V., Beer, S., Bauer, W., Neubauer, S., Ertl, G., Allolio, B. and Callies, F. (2003) Effect of testosterone on post-myocardial infarction remodeling and function. Cardiovascular Research 57, 370-378.
Nakao, A., Sakagami, K., Nakata, Y., Komazawa, K., Amimoto, T., Nakashima, K., Isozaki, H., Takakura, N. and Tanaka, N. (2000) Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. Journal of Gastroenterology 335, 557-562.
O'Sullivan, A.J., Kennedy, M.C., Casey, J.H., Day, R.O., Corrigan, B. and Wodak, A.D. (2000) Anabolic-androgenic steroids: Medical assessment of present, past and potential users. Medical Journal of Australia 173, 323-327.
Palatini, P., Giada, F., Garavelli, G., Sinisi, F., Mario, L., Michielleto, M. and Baldo-Enzi, G. (1996) Cardiovascular effects of anabolic steroids in weight-trained subjects. Journal of Clinical Pharmacology 36, 1132-1140.
Parssinen, M., Karila, T., Kovanen, V. and Seppala, T. (2000) The effect of supraphysiological doses of anabolic androgenic steroids on collagen metabolism. International Journal of Sports Medicine 21, 406-411.
Parssinen, M., Kujala, U., Vartiainen, E., Sarna, S. and Seppala, T. (2000) Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. International Journal of Sports Medicine 21, 225-227.
Perry, P.J., Lund, B.C., Deninger, M.J., Kutscher, E.C., and Schneider, J. (2005) Anabolic steroid use in weightlifters and bodybuilders. An internet survey of drug utilization. Clinical Journal of Sports Medicine 15, 326-330.
Pertusi, R., Dickerman, R.D. and McConathy, W.J. (2001) Evaluation of aminotransferases elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis. Journal of American Osteopathic Association 101, 391-394.
Petersson, A., Garle, M., GranathF., and Thiblin, I. (2006) Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study. Drug and Alcohol Dependence 81, 215-220.
Sader, M.A., Griffiths, K.A., McCredie, R.J., Handelsman, D.J. and Celermajer D.S. (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. Journal of American College of Cardiology 37, 224-230.
Schmidt, P.J., Berlin, K.L., Danacceau, M.A., Neeren, A., Haq, N.A., Roca, C.A. and Rubinow, D.R. (2004) The effects of pharmacologically induced hypogonadism on mood in healthy men. Archives of General Psychiatry 61, 997-1004.
Socas, L., Zumbardo, M., Perez-Luzardo, O., Ramos, A., Perez, C., Hernandez, J.R. and Boada, L.D. (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. British Journal of Sports Medicine 39, e27.
Strawford, A., Barbieri, T, Van Loan, M., Parks, E., Catlin, D, Barton, N., Neese, R., Christiansen, M., King, J. and Hellerstein, M.K. (1999) Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss. Journal of American Medical Association 2281, 1282-1290.
Tagarakis, C.V.M., Bloch, W., Hartmann, G., Hollmann, W. and Addicks, K. (2000) Testosterone-propionate impairs the response of the cardiac capillary bed to exercise. Medicine and Science in Sports and Exercise 32, 946-953.
Tanaka, K., Sakai, H., Hashizume, M. and Hirohata, T. (2000) Serum testosterone; estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Research 60, 5106-5110.
Tikkanen, H.O., Hamalainen, E., Sarna, S., Adlercreutz, H. and Harkonen M. (1998) Associations between skeletal muscle properties, physical fitness, physical activity and coronary heart disease risk factors in men. Atherosclerosis 137, 377-389.
Yesalis, C.E., Courson, S.P. and Wright, J. (2000) History of anabolic steroid use in sport and exercise. In: Anabolic steroids in sport and exercise. Ed: Yesalis, C.E. 2nd edition Champaign, IL: Human Kinetics. 51-71.